Silicon Hills Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,877
Closed -$224K 96
2022
Q1
$224K Sell
4,877
-48
-1% -$2.29K 0.14% 100
2021
Q4
$302K Sell
4,925
-302
-6% -$20.9K 0.19% 97
2021
Q3
$391K Hold
5,227
0.27% 78
2021
Q2
$483K Sell
5,227
-9,023
-63% -$767K 0.38% 60
2021
Q1
$1.26M Sell
14,250
-6,226
-30% -$618K 1.14% 26
2020
Q4
$1.91M Buy
20,476
+14,825
+262% +$1.18M 1.73% 18
2020
Q3
$360K Buy
5,651
+1,266
+29% +$74.2K 0.37% 60
2020
Q2
$229K Buy
+4,385
New +$188K 0.27% 69
2020
Q1
Sell
-2
Closed -$137 75
2019
Q4
$137 Buy
+2
New +$64 0.11% 85

Other funds holding ARKG

Silicon Hills Wealth Management's ARKG Position: Q2 2022 in Review

Silicon Hills Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,877 shares — an estimated $224K sold.

Silicon Hills Wealth Management first reported a position in ARKG in Q4 2019 and held it in 9 quarters. The position peaked at $1.91M in Q4 2020. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Silicon Hills Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Silicon Hills Wealth Management sold 4,877 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $224K.
  • Silicon Hills Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 9 quarters.
  • Silicon Hills Wealth Management's ARK Genomic Revolution ETF position peaked at $1.91M in Q4 2020.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Silicon Hills Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.